SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021470
Filing Date
2018-08-13
Accepted
2018-08-13 16:31:23
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20180630.htm 10-Q 945716
2 EX-10.2 cue-ex102_149.htm EX-10.2 95742
3 EX-10.3 cue-ex103_150.htm EX-10.3 93171
4 EX-31.1 cue-ex311_7.htm EX-31.1 18365
5 EX-31.2 cue-ex312_8.htm EX-31.2 18548
6 EX-32.1 cue-ex321_455.htm EX-32.1 11286
  Complete submission text file 0001564590-18-021470.txt   3914025

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cue-20180630.xml EX-101.INS 700825
8 XBRL TAXONOMY EXTENSION SCHEMA cue-20180630.xsd EX-101.SCH 36896
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20180630_cal.xml EX-101.CAL 30637
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20180630_def.xml EX-101.DEF 97796
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20180630_lab.xml EX-101.LAB 270947
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20180630_pre.xml EX-101.PRE 200772
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 181012629
SIC: 2834 Pharmaceutical Preparations